About Macular Degeneration Treatment
In macular degeneration, early diagnosis is very important for protecting vision. Especially in the wet type, intravitreal injection therapies can bring the disease under control.
Macular degeneration has two main forms, dry and wet. The dry type progresses more slowly, whereas in the wet type abnormal vessels developing under the macula leak and can cause rapid vision loss; this form is controlled with intravitreal injection therapies.
Treatment consists of intravitreal (anti-VEGF) injection therapies, vitamin and support treatments in suitable patients and regular OCT follow-up. For the symptoms, see our Macular Degeneration page.
Who Is It For and When Is It Used?
Macular degeneration treatment is planned in the following situations:
- Wet type macular degeneration: Intravitreal injection in active cases with leakage and bleeding under the macula.
- Seeing straight lines as wavy: In metamorphopsia (distortion) and central blurring complaints.
- Dry type monitoring: Follow-up and support treatments to slow progression.
- High-risk patients: Close follow-up in those carrying risk factors such as smoking, family history and advanced age.
Treatment Methods
The main methods used in macular degeneration:
- Intravitreal injection therapies: Applied especially in the wet type; can reduce fluid under the retina, control the risk of bleeding and slow the progression of vision loss.
- Vitamin and support treatments: May be used as support in some dry type patients.
- Regular OCT follow-up: Plays an important role in monitoring the progression of the disease and timing of treatment.
Featured Treatments
Intravitreal Injection
Anti-VEGF therapy that suppresses abnormal vessels in wet type macular degeneration.
Planning
The need for injection is planned based on OCT findings.
Injection
The drug is applied into the eye under sterile conditions.
Check-up
The response to treatment is monitored regularly.
Vision Protected
Follow-up & Support
In the dry type, nutritional support, risk control and regular OCT follow-up are essential.
Vitamin
Support is assessed in suitable patients.
Prevention
Smoking cessation and blood-pressure control are advised.
Monitoring
Conversion to wet type is monitored with OCT.
Progression Slowed
A change in your central vision?
The treatment plan is created together based on the type and OCT findings.
Benefits & Aftercare
What Treatment Offers
Early, regular injection therapy is decisive in protecting central vision.
- Slowing vision loss
- Reduction of fluid under the macula
- Control of bleeding risk
Aftercare & Follow-up
Regular OCT and home monitoring are important to managing the process.
- Regular OCT checks
- Home monitoring with the Amsler test
- Smoking cessation and healthy diet